• Product NamePlerixafor
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityPlerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.
• Target NameCXCR antagonist
• CAS No. 110078-46-1
• Calculated MW 502.78
• Formulation C28H54N8
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Other
  SMILES:C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1
  Pathways:Autophagy; GPCR/G Protein; Immunology/Inflammation
  Receptor:CXCL12; CXCR4
  Boling pt:
  Melting pt:
  Solubility:Ethanol: 100 mg/mL (198.89 mM); Water: 3 mg/mL warmed (5.96 mM)
  Appearance:White Crystalline Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Nishimura Y, et al. J Invest Dermatol. 2012, 132(3 Pt 1), 711-720.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting